Inflammatory gene polymorphisms and susceptibility to kawasaki disease and its arterial sequelae

Pediatrics

Volumn 122, Issue 3, 2008, Pages

  Cheung, Yiu Fai ^a   Huang, Guo Ying ^b   Chen, Shu Bao ^c   Liu, Xiao Qin ^b   Xi, Li ^b   Liang, Xue Cun ^b   Huang, Mei Rong ^c   Chen, Sun ^c   Huang, Li Su ^c   Liu, Xiao Qing ^c   Chan, Koon Wing ^a   Lau, Yu Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Arteries; Gene polymorphisms; Kawasaki disease

Indexed keywords

C REACTIVE PROTEIN; GENOMIC DNA; IMMUNOGLOBULIN; TUMOR NECROSIS FACTOR ALPHA; DNA;

ARTICLE; BODY MASS; CAROTID ARTERY DISEASE; CHILD; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFLAMMATION; INTIMA; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; THICKNESS; TUNICA MEDIA; ALLELE; BLOOD; CLINICAL TRIAL; COMMON CAROTID ARTERY; COMPARATIVE STUDY; ECHOGRAPHY; ELASTICITY; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; HONG KONG; INCIDENCE; METABOLISM; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; VASCULAR RESISTANCE;

ALLELES; C-REACTIVE PROTEIN; CAROTID ARTERY, COMMON; CHILD; DNA; ELASTICITY; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HONG KONG; HUMANS; INCIDENCE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR RESISTANCE;

EID: 51649085882     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-0646     Document Type: Article

References (49)

1. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94(6):1379-1385
2. Sugimura T, Kato H, Inoue O, Takagi J, Fududa T, Sato N. Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr. 1992;121(5 pt 1):684-688
3. Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol. 2004;43(1):120-124
4. Cheung YF, Ho MH, Tam SC, Yung TC. Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart. 2004;90(11):1281-1285
5. Noto N, Okada T, Yamasuge M, et al. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics. 2001; 107(5):1095-1099
6. Dhillon R, Clarkson P, Donald AE, et al. Endothelial dysfunction late after Kawasaki disease. Circulation. 1996;94(9): 2103-2106
7. Cheung YF, Wong SJ, Ho MH. Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Child. 2007;92(1):43-47
8. Dalla Pozza R, Bechtold S, Urschel S, Kozlik-Feldmann R, Netz H. Subclinical atherosclerosis, but normal autonomic function after Kawasaki disease. J Pediatr. 2007;151(3):239-243
9. Rowley AH, Shulman ST. Kawasaki syndrome. Pediatr Clin North Am. 1999;46(2):313-329
10. Madsen HO, Videm V, Svejgaard A, Svennevig JL, Garred P. Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet. 1998;352(9132):959-960
11. Biezeveld MH, Kuipers IM, Geissler J, et al. Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease. Lancet. 2003;361(9365): 1268-1270
12. Quasney MW, Bronstein DE, Cantor RM, et al. Increased frequency of alleles associated with elevated tumour necrosis factor-α levels in children with Kawasaki disease. Pediatr Res. 2001;49(5):686-690
13. Rocha V, Franco RF, Porcher R, et al. Host defence and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood. 2002;100(12):3908-3918
14. Foster CB, Lehrnbecher T, Mol F, et al. Host defense molecule polymorphisms influence the risk of immune-mediated complications in chronic granulomatous disease. J Clin Invest. 1998; 102(12):2146-2155
15. Brull DJ, Serrano N, Zito F, et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;23(11):2063-2069
16. Hage FG, Szalai AJ. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol. 2007;50(12):1115-1122
17. D'Aiuto F, Casas JP, Shah T, Humphries SE, Hingorani AD, Tonetti MS. C-reactive protein ( + 1444C→T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis. 2005;179(2):413-417
18. Marsik C, Sunder-Plassmann R, Jilma B, et al. The C-reactive protein +1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia. Clin Chem. 2006; 52(10):1952-1957
19. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res. 2001;89(9):763-771
20. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol. 1990;56(1):29-36
21. Leung DY, Geha RS, Newburger JW, et al. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med. 1986;164(6): 1958 -1972
22. Louis E, Franchimont D, Piron A, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-a production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol. 1998;113(3):401-406
23. Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo, Japan: Ministry of Health and Welfare; 1984
24. Kawasaki T, Sasayama S, Yagi S, Asakawa T, Hirai T. Non- invasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc Res. 1987; 21(9):678-687
25. Miller SA, Dykes DD, Polesky HF. A sample salting procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215
26. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992;1(5):353
27. Yan M, Zhao L, Zheng F, Sun X, Zhang Y, Wang C. The relationship between gene polymorphism and CRP level in a Chinese Han population. Biochem Genet. 2007;45(1-2):1-9
28. Chen R, Fang M, Cai Q, et al. Tumor necrosis factor alpha - 308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China. Rheumatol Int. 2007;28(2): 121-126
29. Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19(1):149-150
30. Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606-2612
31. Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149(2):237-240
32. Eklund C, Kivimaki M, Islam MS, et al. C-reactive protein genetics is associated with carotid artery compliance in men in the Cardiovascular Risk in Young Finns Study. Atherosclerosis. 2008;196(2):841-848
33. Yasojima K, Schwab C, McGeer EG, McGeer PL. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol. 2001;158(3):1039-1051
34. Wang HW, Sui SF. Dissociation and submit rearrangement of membrane-bound human C-reactive proteins. Biochem Biophys Res Commun. 2001;288(1):75-79
35. Slyper AH. What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. J Clin Endocrinol Metab. 2004;89(7):3089-3095
36. Lange LA, Carlson CS, Hindorff LA, et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA. 2006;296(22): 2703-2711
37. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol. 1999;66(4):562-566
38. McGuire W, Hill AV, Kwjatkowski D. Variation in the TNF-a promoter region associated with susceptibility to cerebral malaria. Nature. 1994;371(6497):508-511
39. Warzocha K, Ribero P, Bienvenu J, et al. Genetic polymorphisms in the tumor necrosis factor locus influence non- Hodgkin's lymphoma outcome. Blood. 1998;91(10):3574-3581
40. Sýkora J, Subrt I, Didek P, et al. Cytokine tumour necrosis factor-alpha: a promoter gene polymorphism at position -308 G→ A and pediatric inflammatory bowel disease-implications in ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr. 2006;42(5):479-487
41. Kamizono S, Yamada A, Higuchi T, Kato H, Itoh K. Analysis of tumour necrosis factor-a production and polymorphisms of the tumour necrosis factor-a gene in individuals with a history of Kawasaki disease. Pediatr Int. 1999;41(4):341-345
42. Chien YH, Chang KW, Yang YH, Lu MY, Lin YT, Chiang BL. Association between levels of TNF-alpha and TNF-alpha promoter - 308 A/A polymorphism in children with Kawasaki disease. J Formos Med Assoc. 2003;102(3):147-150
43. Skoog T, Dichtl W, Boquist S, et al. Plasma tumour necrosis factor-a and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J. 2002;23(5):376-383
44. Skoog T, van't Hooft FM, Kallin B, et al. A common functional polymorphism (C→.A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet. 1999;8(8):1443-1449
45. Mäki-Petäjä KM, Hall FC, Booth AD, et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-aα therapy. Circulation. 2006;114(11):1185-1192
46. Del Porto F, Laganá B, Lai S, et al. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology (Oxford). 2007;46:1111-1115
47. Breunis WB, Biezeveld MH, Geissler J, et al. Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease. Clin Exp Immunol. 2007;150(1):83-90
48. Cheung YF, Ho MH, Ip WK, Fok SF, Yung TC, Lau YL. Modulating effects of mannose binding lectin genotype on arterial stiffness in children after Kawasaki disease. Pediatr Res. 2004; 56(4):591-596
49. The International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437(7063):1299-1320